25 results about "Oroxylum indicum" patented technology

The invention relates to a traditional Chinese medicine composition which comprises more than 1.09 permillage of ephedrine hydrochloride, more than 0.86 permillage of pseudoephedrine hydrochloride, more than 0.17 permillage of peiminine, more than 0.03 permillage of peimine, more than 0.17 permillage of chrysin-7-O-glucuronide, more than 0.002 permillage of glycyrrhetinic acid, more than 11.87 permillage of amygdalin and more than 0.01 permillage of neotuberostemonine. The oral liquid is prepared from more than 2.16 per mill of glycyrrhizic acid, more than 1.97 per mill of oroxylin A, more than 1.97 per mill of oroxylin B, more than 1.23 per mill of liquiritin, more than 0.59 per mill of apiose liquiritin, more than 0.55 per mill of baicalin, more than 0.23 per mill of chlorogenic acid, more than 0.18 per mill of praeruptorin A, more than 0.15 per mill of wild melanosin, more than 0.14 per mill of methyephedrine hydrochloride, more than 0.13 per mill of isoliquiritin, more than 0.13 per mill of neochlorogenic acid and more than 0.13 per mill of cryptochlorogenic acid. The composition is prepared from more than 0.10% of peimine, more than 0.08% of baicalein, more than 0.05% of praeruptorin B, more than 0.04% of praeruptorin C, more than 0.011% of xanthoxylin and more than 0.0006% of formononetin.

The present invention discloses Anti-hirsutism compositions, use and methods for managing hirsutism in a subject using the composition comprising turmeric oil standardized to contain Aromatic Turmerone (ar-Turmerone), Eflornithine; Nigella sativa extract; Oroxylum indicum extract; and Licorice extract either individually or combinations thereof. The invention also discloses use of the above composition in inhibiting the activity of ornithine decarboxylase and 5-α-reductase.

A traditional Chinese medicine composition for treating acute and chronic inflammation of the ear, nose, and throat, and its preparation method, characterized in that, by weight, it is made from the following traditional Chinese medicinal materials: 10-30 parts of Lycium chinense root bark, 8-30 parts of Gardenia jasminoides, 10-30 parts of Sanguisorba officinalis root bark, 8-25 parts of Schizonepeta tenuifolia root bark, 6-16 parts of Angelica dahurica root bark, 10-35 parts of Asparagus cochinchinensis root bark, 11-35 parts of Platycodon grandiflorus root bark, 7-46 parts of Paeonia lactiflora root bark, 8-46 parts of Rehmannia glutinosa root bark, and 5-10 parts of Oroxylum indicum root bark. 14 parts of the following ingredients are used: Astragalus membranaceus 12-50 parts, Magnolia biondii 10-30 parts, Trichosanthes kirilowii 10-35 parts, Stellaria dichotoma 5-20 parts, Imperata cylindrica 7-30 parts, Fagopyrum dibotrys 10-35 parts, Coix lacryma-jobi 13-60 parts, Lepidium apetalum 5-15 parts, Gypsum fibrosum 14-50 parts, Sophora tonkinensis 3-20 parts, Lonicera japonica 12-50 parts, Xanthium sibiricum 6-35 parts, Ephedra sinica 6-30 parts, and Styrax benzoin 1-3 parts. After grinding into powder, the mixture is steamed with rice wine to obtain pills. The principle of treating all three (ear, nose, and throat) simultaneously, considering the anatomical structure and physiological function of the ear, nose, and throat, aims to reduce cross-infection, promote recovery, and achieve ideal medicinal properties.

This application provides a traditional Chinese medicine tea for the prevention or treatment of upper respiratory tract infections, its preparation method, and its application. The tea is made from the following raw materials in parts by weight: 2-4 parts of Scrophularia ningpoensis, 2-4 parts of Ophiopogon japonicus, 1-3 parts of Adenophora stricta, 2-4 parts of Adenophora stricta, 2-4 parts of Scutellaria baicalensis, 0.5-1.5 parts of Platycodon grandiflorus, 0.5-1.5 parts of Belamcanda chinensis, 0.5-1.5 parts of Lonicera japonica, 0.5-1.5 parts of Oroxylum indicum, and 1-3 parts of Glycyrrhiza uralensis. The raw materials in this application are formulated and the components of the traditional Chinese medicine are quantified and proportioned through precise cutting parameters, and the preservation of the precisely cut herbs is controlled. This allows the tea to: nourish Yin and moisten dryness, replenish Qi and generate fluids, clear heat from the upper burner, treat dry and itchy throat, sore throat, dry cough, and prevent upper respiratory tract infections.

The invention discloses a traditional Chinese medicine preparation with radix saposhnikoviae and cough relieving effects and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine preparations. The traditional Chinese medicine preparation is prepared from 11 traditional Chinese medicines including radix saposhnikoviae, herba schizonepetae, herba menthae, semen oroxyli, radix glycyrrhizae, cortex dictamni, flos mume, honey-fried flos farfarae, fructus nandinae, radix platycodonis and roasted fructus chebulae. The preparation method comprises the following steps: distilling to extract volatile oil, decocting dregs and other medicinal materials with water, filtering, concentrating, adding auxiliary materials, granulating, drying, spraying the volatile oil, and uniformly mixing to prepare granules. The preparation can dispel wind and relieve exterior syndrome, clear away lung-heat and relieve sore-throat, relieve cough and reduce sputum and quickly relieve core symptoms such as throat itching and instant cough aiming at wind cough caused by wind evil invading lung and lung qi dispersing, is quick in effect taking and exact in curative effect, solves the problems that an existing preparation is not high in pertinence and easy to relapse, is suitable for related diseases such as cough after cold, and provides a new traditional Chinese medicine choice for wind cough treatment.

The invention provides a traditional Chinese medicine composition with an effect of treating chronic pharyngitis and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from 30-50 parts of phyllanthus emblica, 20-40 parts of oroxylum indicum, 15-25 parts of terminalia chebula, 40-60 parts of roughhaired holly root, 15-35 parts of radix ophiopogonis, 5-15 parts of subprostrate sophora, 25-45 parts of selfheal, 10-30 parts of folium mori, 15-35 parts of chrysanthemum, 5-15 parts of radix scrophulariae, 8-18 parts of scaphium scaphigerum, 150-200 parts of wild chrysanthemum and 40-50 parts of honeysuckle. The preparation method comprises the following steps: (1) pretreatment and enzymolysis of rhizome raw materials; (2) whole-formula mixed extraction; (3) two-stage concentration; and (4) drying. Wild chrysanthemum focuses on clearing away heat and toxic materials and relieving swelling and pain The honeysuckle can help the wild chrysanthemum flower to clear away heat and toxic materials and dispel wind and heat. The two components are matched with the phyllanthus emblica and the like, and are prepared through an ultrasonic enzymolysis-gradient alcohol precipitation process, so that the curative effect is improved, and the recurrence rate is reduced.

The invention provides a traditional Chinese medicine composition for treating chronic pharyngitis and a preparation method thereof, the composition is composed of thunberg fritillary bulb, raw oyster, pinellia ternate, platycodon grandiflorum, blackberry lily, plum blossom, perilla leaf, fructus forsythiae, moutan bark, oroxylum indicum, bamboo leaf, reed rhizome, dark plum, honey-fried licorice root and other medicinal materials, and through scientific compatibility, the effects of clearing heat and reducing phlegm, relieving sore-throat and removing stasis, and soothing liver-qi stagnation are achieved. A step-by-step extraction process is adopted and comprises the steps of firstly decocting raw oysters, combining two times of water extraction, distilling and extracting volatile oil and the like, and active ingredients are effectively reserved. The composition can significantly reduce levels of pharyngeal inflammatory factors IL-6 and TNF-alpha and promote secretion of respiratory tract mucus, and has good anti-inflammatory and phlegm-reducing effects; safety evaluation shows that the liver and kidney function indexes are not abnormal after 28 days of continuous administration; the preparation can be prepared into granules or oral liquid, is convenient for clinical application, is suitable for patients with phlegm-qi stagnation type chronic pharyngitis, can be combined with western medicines for use to enhance the curative effect, and has wide popularization and application prospects.

The invention belongs to the technical field of traditional Chinese medicines, and provides a traditional Chinese medicine composition for delayed fracture healing. In the traditional Chinese medicine composition, the traditional Chinese medicine composition is prepared from abelmoschus manihot, dried alum, leech, centipede, scorpion, hedgehog hide, liquorice, elderberry, oroxylum indicum, uncaria rhynchophylla, medlar, safflower, pawpaw, radix curcumae, radix stephaniae tetrandrae, fried mustard seed, citron, fried rice sprout, fried malt and fructus polygoni orientalis, all the medicines are combined, and the effect is exact. In the formula, the compatibility of monarch, minister, assistant and guide is scientific and reasonable, the raw materials are various and are different from the general effect of enhancing a single medicine, a synergistic relationship is adopted, and the traditional Chinese medicine composition can effectively relieve swelling and pain, promote blood stasis dissipation, smooth channels and blood circulation, nourish muscles and bones, promote fracture to delay healing and reduce the pain of a patient.

This invention relates to the field of traditional Chinese medicine composition technology, and particularly to an oral traditional Chinese medicine composition for treating multiple myeloma and its preparation method. It comprises the following components in parts by weight: Bupleurum chinense 10-12 parts, Cyperus rotundus 8-10 parts, Curcuma longa 8-10 parts, Oroxylum indicum 5-6 parts, Angelica sinensis 8-10 parts, Paeonia lactiflora 8-10 parts, Atractylodes macrocephala 10-12 parts, Poria cocos 10-12 parts, Codonopsis pilosula 8-10 parts, Glycyrrhiza uralensis (processed) 5-6 parts, Agrimonia pilosa 6-8 parts, Bambusa textilis 8-10 parts, Mentha haplocalyx 4-6 parts, and Zingiber officinale 4-6 parts. The composition provided by this invention not only directly inhibits the growth of myeloma cells, but also comprehensively improves the survival prognosis of model animals by regulating liver and spleen function, improving immune status, and reducing phlegm-heat and blood stasis. It provides a stable, safe, and easily promoted oral traditional Chinese medicine preparation for the clinical treatment of multiple myeloma.

This invention belongs to the field of medical and nursing care products technology, specifically relating to a traditional Chinese medicine composition for chronic wounds that promotes antibacterial and tissue regeneration, and its application. The raw materials for this composition include Paris polyphylla, dragon's blood, frankincense, myrrh, rhubarb, Phellodendron bark, calamine, pearl powder, Oroxylum indicum, sappanwood, and Rosa laevigata leaves. When this traditional Chinese medicine combination is prepared into a topical ointment and applied to the wound, it possesses potent antibacterial, blood-activating, and tissue-regenerating effects, achieving simultaneous intervention at multiple stages. This improves wound healing and treatment outcomes, addressing issues such as bacterial resistance, insufficient regenerative capacity of modern dressings, and insufficient early-stage antibacterial and anti-inflammatory effects in existing chronic wound treatments. This provides a safe, effective, and economical new treatment option for clinical practice.

The invention discloses application of oroxylum indicum total flavonoids in preparation of a medicine for treating uveitis. Experiments prove that the eye drops taking the oroxylum indicum total flavonoids or the oroxylin A as the active ingredient can reduce the uveitis eye inflammation and retina injury degree and reduce the infiltration quantity of inflammatory cells. The oroxylum indicum general flavone is taken as an oral medicine, so that inflammatory infiltration cells of a vitreous cavity and an iris-ciliary body can be reduced, bleeding symptoms can be effectively improved, hyperplasia of iris-ciliary body tissues can be inhibited, and infiltration of leukocytes of aqueous humor in mouse eyes can be effectively inhibited.

The invention relates to a herbal preparation in the form of film-coated tablets for the supportive treatment of allergic rhinitis and sinusitis, and a process for preparing such a preparation. The preparation according to the invention contains herbal extracts obtained from a mixture of medicinal herbs including Bupleurum root (Radix Bupleurum), Platycodon grandiflorus root (Radix Platycodi grandiflori), Xanthium strumarium fruit (Fructus Xanthii strumarii), Magnolia officinalis flower (Flos Magnoliae), and Oroxylum indicum bark (Cortex Oroxyli indici), in which each herb is used in appropriate amounts to create synergistic anti-inflammatory, anti-allergic, decongestant, expectorant, and immune-enhancing effects on the respiratory mucosa. The preparation also includes a film-coating system containing a film-forming polymer, plasticizer, and coloring agent, along with tablet-forming excipients such as preservatives, fillers, stabilizers, and anti-caking agents in appropriate proportions to create a highly stable film-coated tablet.The preparation according to the invention has the advantages of preserving the active ingredients of the medicinal herbs, increasing stability, improving bioavailability, being convenient to use, and contributing to enhancing the effectiveness of supporting the treatment of symptoms of allergic rhinitis and sinusitis. It is also safe for long-term use because the preparation contains herbal extracts of natural origin that have been used for a long time in traditional medicine, and does not contain synthetic vasoconstrictors, corticosteroids, or antibiotics. In addition, the extraction and purification process helps remove impurities and reduce irritating components, thereby limiting the risk of unwanted side effects with prolonged use.

The invention relates to the field of cosmetics, in particular to a preparation process of an anti-aging and anti-inflammatory skin care product based on a compound of oroxylum indicum freeze-dried powder and cordyceps sobolifera polysaccharide, which specifically comprises the following steps: step A, performing ultrasonic-assisted extraction and filtration on oroxylum indicum powder by using an ethanol aqueous solution to obtain an oroxylum indicum extracting solution; step B, carrying out reduced pressure rotary evaporation on the oroxylum indicum extracting solution, and concentrating until no ethanol is distilled off, so as to obtain an oroxylum indicum concentrated solution; the invention develops a novel oroxylum indicum freeze-dried powder-cordyceps sobolifera polysaccharide compound extract, and the stability and permeability of the compound extract are improved through liposome coating, so that the effects of efficiently resisting aging and inflammation are achieved. The compound has excellent oxidation resistance, has anti-aging and anti-inflammatory effects, and is natural, mild and non-irritating.

The invention discloses an application of oroxylum indicum total flavonoids in preparation of a medicine for treating atopic dermatitis. Tests prove that the oroxylum indicum total flavonoids can remarkably relieve skin inflammation, erythema and edema symptoms of atopic dermatitis model animals and effectively improve the skin barrier function; meanwhile, the oroxylum indicum total flavonoids can reduce the infiltration quantity of mast cells, do not influence the index of organs of mice, and can be used as an active ingredient for safely treating atopic dermatitis to prepare related external preparations.

The invention discloses a traditional Chinese medicine for treating infantile adenoid hypertrophy and a preparation method thereof. The traditional Chinese medicine is prepared from nine medicinal materials including pericarpium citri reticulatae, thunberg fritillary bulb, selfheal, oroxylum indicum, platycodon grandiflorum, radix scrophulariae, semen coicis, biond magnolia flower and radix saposhnikoviae, clinical research shows that the medicine can remarkably improve symptoms such as nasal obstruction, snoring and mouth breathing of sick children and has the effect of reducing adenoid hypertrophy, the total effective rate can reach 90.15%, and safety is good. The traditional Chinese medicine overcomes the defects that existing western medicines have many side effects after being used for a long time and the operation is likely to relapse, embodies the characteristic of treating both symptoms and root causes of the traditional Chinese medicine, and has good clinical application prospects.

This invention provides a traditional Chinese medicine composition for treating chronic enteritis, relating to the field of traditional Chinese medicine pharmaceutical technology. The invention provides a traditional Chinese medicine composition for treating chronic enteritis, composed of Gentiana scabra, Sophora flavescens, Phellodendron chinense, Sparganium stoloniferum, Oroxylum indicum, Areca catechu, Paeonia lactiflora, Rosa laevigata, Hematite, Codonopsis pilosula, Magnolia officinalis, Raphanus sativus, and Prunus persica. This traditional Chinese medicine composition has the effects of clearing heat and drying dampness, strengthening the spleen and replenishing qi, promoting qi circulation and eliminating stagnation, astringing the intestines and stopping diarrhea, and promoting blood circulation and relieving pain. The purpose of this traditional Chinese medicine composition is to regulate the overall function of the body, enhance the spleen and stomach's digestive function, improve intestinal qi and blood circulation and water metabolism, thereby achieving the purpose of treating chronic enteritis. This traditional Chinese medicine composition can significantly alleviate weight loss, fecal condition, and hematochezia in a mouse model of DSS-induced chronic enteritis. It can significantly improve colonic shortening and pathological changes in colonic tissue in the DSS-induced chronic enteritis mouse model, restore damaged tissue structure, reduce the number and infiltration range of inflammatory cells, and has good anti-inflammatory effects. This traditional Chinese medicine composition has broad application prospects in the preparation of drugs for treating chronic enteritis.

The invention relates to a method for detecting a traditional Chinese medicine composition, the traditional Chinese medicine composition is prepared from ephedra, bitter apricot kernel, platycodon grandiflorum, radix peucedani, thunberg fritillary bulb, radix stemonae, radix glehniae, oroxylum indicum and liquorice, the method is characterized in that the detection comprises the step of carrying out UPLC-TQ-MS detection on a test solution of the traditional Chinese medicine composition, and the chromatographic conditions of the UPLC-TQ-MS detection comprise: the specification is 3.0 * 50 mm; an Agilent Eclipse Plus C18 chromatographic column with the size of 1.8 [mu] m is adopted; a mobile phase is an A (0.08% formic acid water (containing 0.0625% ammonium formate) solution)-B (acetonitrile) system.

This invention provides a traditional Chinese medicine preparation for treating Hashimoto's thyroiditis and its preparation method, belonging to the field of traditional Chinese medicine pharmaceutical technology. The preparation is made from Curcuma zedoaria, oyster shell, Eclipta prostrata, Ligustrum lucidum, Sargassum, processed Aconitum carmichaelii, Cremastra appendiculata, Duchesnea indica, Hedyotis diffusa, Artemisia capillaris, Oroxylum indicum, and cinnamon. The formula is meticulously formulated, closely addressing the core pathogenesis of Hashimoto's thyroiditis: "phlegm and blood stasis, spleen and kidney deficiency, and nutritional imbalance." It focuses on "eliminating masses and dispersing nodules, promoting qi and blood circulation," fully embodying the TCM diagnostic and treatment approach of "differentiating syndromes and treating accordingly, addressing both the root cause and symptoms." This invention's preparation has a good therapeutic effect on Hashimoto's thyroiditis, effectively improving thyroid autoimmune disorders, regulating thyroid function, and alleviating symptoms of local thyroid inflammation in experimentally induced Hashimoto's thyroiditis rats. Further clinical observation studies have found that this preparation significantly improves the overall effective rate of clinical treatment for Hashimoto's thyroiditis patients, providing a new approach to the treatment of this condition.

The invention relates to a barrier repairing and relieving composition suitable for sensitive skin and application thereof. The composition comprises ottelia acuminata extract, polygonatum odoratum extract, oroxylum indicum seed extract and butterflybush flower extract. The four plant extracts including the ottelia acuminata extract, the radix polygonati officinalis extract, the oroxylum indicum seed extract and the butterflybush flower extract are creatively combined to form a brand-new composition mode, the four plant extracts are scientifically matched and cooperate with one another, and the composition has excellent skin barrier repairing, anti-inflammatory and soothing and moisturizing effects and is free of toxic and side effects. Specifically, the expression of inflammatory factors TNF-alpha, IL-6 and NO can be inhibited, and the expression of FLG, LOR and AQP-3 proteins can be promoted.

The invention relates to a traditional Chinese medicine composition which is prepared from active ingredients extracted from 1-3 parts of roasted ephedra, 1-10 parts of semen armeniacae amarae, 1-6 parts of platycodon grandiflorum, 1-6 parts of radix peucedani, 1-6 parts of thunberg fritillary bulb, 1-6 parts of radix stemonae, 1-3 parts of oroxylum indicum, 1-10 parts of radix glehniae and 1-3 parts of liquorice in percentage by mass as follows: more than 1.09% o of ephedrine hydrochloride, more than 0.86% o of pseudoephedrine hydrochloride and the balance of water. The traditional Chinese medicine composition is prepared from more than 0.17 per mill of peiminine, more than 0.03 per mill of peimine, more than 0.17 per mill of chrysin-7-O-glucuronide, more than 0.002 per mill of glycyrrhetinic acid, more than 11.87 per mill of amygdalin and more than 0.01 per mill of neotuberostemonine.

The invention belongs to the technical field of cosmetics, and particularly relates to a composition with repairing and tightening effects, cosmetics and application of the composition and the cosmetics. Specifically, the cymbidium kanran extract and the persimmon leaf extract / oroxylum indicum extract / licorice root extract / southern semen cuscutae extract are combined, after compounding, all the components have a synergistic effect, the content of V-type collagen, HSP47, gammaH2AX and chondroitin sulfate can be increased, and skin aging is cooperatively intervened in a multi-target mode. Besides, the skin care product containing the composition is beneficial to improving the skin compactness and the mandibular line angle and width, can enhance the skin moisture content and reduce the percutaneous moisture loss, and has the repairing and compacting effects. The repairing and tightening composition is proved to have the multi-channel regulation and control capability, can enhance the internal repairing potential of the skin from multiple aspects, can be used as a component of cosmetics, especially skin care products, and thus, has a good practical application value.

The invention discloses a GC fingerprint spectrum detection method for traditional Chinese medicine, and belongs to the field of traditional Chinese medicine detection. The traditional Chinese medicine is prepared from nine medicinal materials including pericarpium citri reticulatae, thunberg fritillary bulb, selfheal, oroxylum indicum, platycodon grandiflorum, radix scrophulariae, semen coicis, biond magnolia flower and divaricate saposhnikovia root, and is used for treating the child adenoid hypertrophy, and the method comprises the following steps: preparing a test solution, adopting an HP-5 capillary column, performing analysis under the chromatographic conditions that the split ratio is 30: 1, temperature programming is performed, the temperature of a sample inlet is 290 DEG C, and the temperature of a detector is 300 DEG C, and recording a chromatogram for 075 min. A standard fingerprint spectrum containing 19 common peaks is established by measuring a plurality of batches of samples, the attribution of each peak is defined, and five characteristic components such as eucalyptol and beta-bisabolol are identified. The method is good in stability and high in reproducibility, the constructed fingerprint spectrum is high in characteristic, the method can be used for quality consistency evaluation and production process control of traditional Chinese medicine, and safety and effectiveness of clinical medication are guaranteed.

The invention provides a traditional Chinese medicine compound preparation for auxiliary nursing of hashimoto thyroiditis, and relates to the technical field of traditional Chinese medicine pharmacy. The traditional Chinese medicine compound preparation is prepared from the following traditional Chinese medicinal materials: resina liquidambaris, homalomena occulta, sword brake herb, walnut twig, resina erythrinae, siberian elm bark, polygonum cuspidatum, red-knees herb, perfoliote knotweed herb, akebia fruit, oroxylum indicum, semen brassicae, kadsura longipedunculata, rhizoma dioscoreae nipponicae, ginseng leaf and rhizoma zingiberis. According to the traditional Chinese medicine compound preparation, the autoantibody titers of HT model rat serum TPOAb and TgAb can be effectively reduced, thyroid function indexes FT3, FT4 and TSH are effectively improved, and meanwhile generation and activity of HT model serum inflammatory factors can be effectively inhibited. The traditional Chinese medicine compound preparation disclosed by the invention has a relatively good treatment effect in the aspects of inhibiting autoantibody generation and reducing thyroid damage and can be used for effectively treating hashimoto thyroiditis by inhibiting inflammatory response. The traditional Chinese medicine compound preparation disclosed by the invention is expected to be further developed and researched as a medicine for treating or assisting in treating hashimoto thyroiditis.

The invention relates to a traditional Chinese medicine extract for treating cataract and a preparation method and medical application thereof.The traditional Chinese medicine extract is a traditional Chinese medicine oroxylum indicum acid hydrolysis extract, and the content of total flavonoids is not less than 47% based on the total amount of baicalein and chrysin. The traditional Chinese medicine composition is selected from any dosage form capable of being taken, and the dosage form is selected from tablets, capsules, oral liquid, granules, pills, ointment, dripping pills and injections.

The invention discloses a preparation method and a quality detection method of an oroxylum indicum standard decoction, and relates to the technical field of quality research of traditional Chinese medicinal materials. The preparation method comprises the following steps: weighing a proper amount of oroxylum indicum decoction pieces, putting the oroxylum indicum decoction pieces into a marmite, decocting twice, adding 8 times of water for soaking for 30 minutes for the first time, boiling with strong fire, and decocting with slow fire for 30 minutes; adding 6 times of water for the second time, boiling with strong fire, then decocting with slow fire for 20 minutes, filtering the liquid medicine with 200 meshes, cooling the filtrate to room temperature in a cold water bath, combining the two filtrates, carrying out vacuum concentration at the temperature of 50 DEG C, carrying out vacuum concentration at the absolute vacuum degree of 30-40mbar until the weight ratio of the medicinal material to the fluid extract is about 1: 1, collecting the concentrated solution, and carrying out freeze drying to obtain a sample. According to the method, key quality indexes such as the main content, the characteristic chromatogram and the extract of the oroxylum indicum after the decoction is prepared are measured, the transfer rate is investigated, the component transfer condition after the decoction pieces are transferred to the decoction is measured by an objective quality standard, and the quality degree and the effectiveness of the decoction are ensured.